[go: up one dir, main page]

GB8331514D0 - Visualization method - Google Patents

Visualization method

Info

Publication number
GB8331514D0
GB8331514D0 GB838331514A GB8331514A GB8331514D0 GB 8331514 D0 GB8331514 D0 GB 8331514D0 GB 838331514 A GB838331514 A GB 838331514A GB 8331514 A GB8331514 A GB 8331514A GB 8331514 D0 GB8331514 D0 GB 8331514D0
Authority
GB
United Kingdom
Prior art keywords
metal particles
colloidal metal
visualization method
spectopho
tometric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB838331514A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Priority to GB838331514A priority Critical patent/GB8331514D0/en
Publication of GB8331514D0 publication Critical patent/GB8331514D0/en
Priority to AT84201559T priority patent/ATE64468T1/en
Priority to DE8484201559T priority patent/DE3484710D1/en
Priority to EP84201559A priority patent/EP0158746B1/en
Priority to CA000467203A priority patent/CA1253422A/en
Priority to KR1019840007168A priority patent/KR890001131B1/en
Priority to FI844508A priority patent/FI80345C/en
Priority to JP59244692A priority patent/JPH0643998B2/en
Priority to PT79533A priority patent/PT79533A/en
Priority to AU35825/84A priority patent/AU583484B2/en
Priority to ZA849182A priority patent/ZA849182B/en
Priority to DK557684A priority patent/DK160108C/en
Priority to NZ210309A priority patent/NZ210309A/en
Priority to IL73607A priority patent/IL73607A/en
Priority to ES537926A priority patent/ES8602255A1/en
Priority to NO844672A priority patent/NO163754C/en
Priority to US07/115,652 priority patent/US4775636A/en
Priority to JP5081149A priority patent/JP2601616B2/en
Priority to SG12594A priority patent/SG12594G/en
Priority to HK148/94A priority patent/HK14894A/en
Priority to CY175994A priority patent/CY1759A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/559—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody through a gel, e.g. Ouchterlony technique
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Details Of Television Scanning (AREA)
  • Communication Control (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Conductive Materials (AREA)

Abstract

A method for detecting and/or determining an agglomerate formed by the reaction between a specific binding agent and the corresponding acceptor substance according to the general methodology of blot overlay assays by using colloidal metal particles labelled components which may be visualized as a coloured signal at the surface of the blotting medium characteristic for the colloidal metal particles used or quantitatively determined following art-known spectopho- tometric procedures such as densitometry.
GB838331514A 1983-11-25 1983-11-25 Visualization method Pending GB8331514D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GB838331514A GB8331514D0 (en) 1983-11-25 1983-11-25 Visualization method
AT84201559T ATE64468T1 (en) 1983-11-25 1984-10-31 METHODS FOR VISUAL INDICATION OF THE DIRECT OR INDIRECT DETERMINATION OF THE REACTION BETWEEN A SPECIFIC BINDING AGENT AND THE CORRESPONDING ACCEPTOR SUBSTANCE IN ''BLOT OVERLAY'' ASSAY METHODS.
DE8484201559T DE3484710D1 (en) 1983-11-25 1984-10-31 METHOD FOR THE OPTICAL DISPLAY OF THE DIRECT OR INDIRECT DETERMINATION OF THE REACTION BETWEEN A SPECIFIC BINDING AGENT AND THE CORRESPONDING ACCEPTOR SUBSTANCE IN "BLOT OVERLAY" TEST PROCEDURE.
EP84201559A EP0158746B1 (en) 1983-11-25 1984-10-31 Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays
CA000467203A CA1253422A (en) 1983-11-25 1984-11-07 Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays
KR1019840007168A KR890001131B1 (en) 1983-11-25 1984-11-15 Vosialization method for the direct or indirect detection of the reation between a specific binding agent and the corresponding acceptor substance in blot overlay assays
FI844508A FI80345C (en) 1983-11-25 1984-11-16 VISUALISERINGSFOERFARANDE FOER DIREKT ELLER INDIREKT DETEKTERING AV ETT AGGLOMERAT BILDAT AV ETT SPECIFIKT BINDANDE AEMNE OCH EN MOTSVARANDE ACCEPTORSUBSTANS VID BLOT OVERLAY-BESTAEMNINGAR OCH I DESSA BESTTAEMNINGAR
JP59244692A JPH0643998B2 (en) 1983-11-25 1984-11-21 Agglomeration detection and / or quantification method
PT79533A PT79533A (en) 1983-11-25 1984-11-22 Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays
NO844672A NO163754C (en) 1983-11-25 1984-11-23 PROCEDURE FOR DETECTING OR DETERMINING AN AGGLOMERATED AND A METHOD FOR IMPLEMENTING THE PROCEDURE.
ZA849182A ZA849182B (en) 1983-11-25 1984-11-23 Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays
AU35825/84A AU583484B2 (en) 1983-11-25 1984-11-23 Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays
DK557684A DK160108C (en) 1983-11-25 1984-11-23 Method and equipment for direct or indirect detection of reaction between a specific binding agent and the corresponding acceptor substance
NZ210309A NZ210309A (en) 1983-11-25 1984-11-23 Blot-overlay immunoassay using colloidal metals
IL73607A IL73607A (en) 1983-11-25 1984-11-23 Detection and/or determination of antibody aggregates by immunospectrometric methods using colloidal metallic particles as indicators
ES537926A ES8602255A1 (en) 1983-11-25 1984-11-23 Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays.
US07/115,652 US4775636A (en) 1983-11-25 1987-10-27 Blot overlay assay using colloidal metal particles
JP5081149A JP2601616B2 (en) 1983-11-25 1993-03-17 Test kit
SG12594A SG12594G (en) 1983-11-25 1994-01-26 Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays.
HK148/94A HK14894A (en) 1983-11-25 1994-02-24 Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays
CY175994A CY1759A (en) 1983-11-25 1994-07-15 Visualization method for the direct or indirect detection of the reaction between a specific binding agent and the corresponding acceptor substance in blot overlay assays.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838331514A GB8331514D0 (en) 1983-11-25 1983-11-25 Visualization method

Publications (1)

Publication Number Publication Date
GB8331514D0 true GB8331514D0 (en) 1984-01-04

Family

ID=10552346

Family Applications (1)

Application Number Title Priority Date Filing Date
GB838331514A Pending GB8331514D0 (en) 1983-11-25 1983-11-25 Visualization method

Country Status (19)

Country Link
US (1) US4775636A (en)
EP (1) EP0158746B1 (en)
JP (2) JPH0643998B2 (en)
KR (1) KR890001131B1 (en)
AT (1) ATE64468T1 (en)
AU (1) AU583484B2 (en)
CA (1) CA1253422A (en)
CY (1) CY1759A (en)
DE (1) DE3484710D1 (en)
DK (1) DK160108C (en)
ES (1) ES8602255A1 (en)
FI (1) FI80345C (en)
GB (1) GB8331514D0 (en)
HK (1) HK14894A (en)
IL (1) IL73607A (en)
NO (1) NO163754C (en)
NZ (1) NZ210309A (en)
PT (1) PT79533A (en)
ZA (1) ZA849182B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079172A (en) 1988-11-04 1992-01-07 Board Of Trustees Operating Michigan State University Method for detecting the presence of antibodies using gold-labeled antibodies and test kit

Families Citing this family (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
GB8415998D0 (en) * 1984-06-22 1984-07-25 Janssen Pharmaceutica Nv Staining method
US5958790A (en) * 1984-12-20 1999-09-28 Nycomed Imaging As Solid phase transverse diffusion assay
US5512332A (en) * 1985-10-04 1996-04-30 Immunivest Corporation Process of making resuspendable coated magnetic particles
US5137827A (en) * 1986-03-25 1992-08-11 Midwest Research Technologies, Inc. Diagnostic element for electrical detection of a binding reaction
US4837145A (en) * 1986-06-09 1989-06-06 Liotta Lance A Layered immunoassay using antibodies bound to transport particles to determine the presence of an antigen
AU602694B2 (en) * 1986-06-09 1990-10-25 Ortho Diagnostic Systems Inc. Improved colloidal gold membrane assay
AU7385387A (en) * 1986-06-09 1987-12-10 Ortho Diagnostic Systems Inc. Immunoassay using detection of colloidal gold
US5514602A (en) * 1986-06-09 1996-05-07 Ortho Diagnostic Systems, Inc. Method of producing a metal sol reagent containing colloidal metal particles
EP0254081A3 (en) * 1986-06-30 1988-04-20 Yuko Yoneda Method of detecting specific protein
US5491098A (en) * 1987-03-09 1996-02-13 Janssen Pharmaceutica N.V. Method for depositing metal particles on a marker
CA1340803C (en) * 1987-03-09 1999-10-26 Janssen Pharmaceutica N.V. Method for depositing metal particles on a marker
USRE38430E1 (en) 1987-03-27 2004-02-17 Becton, Dickinson And Company Solid phase chromatographic immunoassay
EP0560410B1 (en) 1987-04-27 2002-10-02 Inverness Medical Switzerland GmbH A test device for performing specific binding assays
US4962023A (en) * 1987-06-22 1990-10-09 Louisiana State University, Agricultural And Mechanical College Single incubation immuno sorbent assay method using particle labels to detect test antigen specific antibodies in presence of other antibodies
US5120643A (en) * 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
JP2581566B2 (en) * 1987-09-30 1997-02-12 和光純薬工業株式会社 Iron colloid-labeled antibody, method for producing the same, and histocytochemical detection method using the same
US5571667A (en) * 1987-10-01 1996-11-05 Chu; Albert E. Elongated membrane flow-through diagnostic device and method
US5006464A (en) * 1987-10-01 1991-04-09 E-Y Laboratories, Inc. Directed flow diagnostic device and method
EP0317001B1 (en) * 1987-11-16 1993-02-03 Janssen Pharmaceutica N.V. A new universally applicable detection system based 0n ultra small colloidal metal particles
NL8702769A (en) * 1987-11-19 1989-06-16 Holland Biotechnology METHOD FOR DETERMINING A TEST SAMPLE OF COMPONENTS OF THE REACTION BETWEEN A SPECIFIC BINDING PROTEIN AND THE ACCOMPANYING BINDABLE SUBSTANCE USING AT LEAST ONE BRANDED COMPONENT, METHOD FOR PREPARING THE MARKED COMPONENT, AND TESTING COMPONENT
GB8800702D0 (en) * 1988-01-13 1988-02-10 Nycomed As Test method & reagent kit therefor
US4952517A (en) * 1988-02-08 1990-08-28 Hygeia Sciences, Inc. Positive step immunoassay
US5202267A (en) * 1988-04-04 1993-04-13 Hygeia Sciences, Inc. Sol capture immunoassay kit and procedure
EP0378621A4 (en) * 1988-05-23 1991-08-28 Steffen Gay Diagnostics and therapy for rheumatoid arthritis
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
CA2002660A1 (en) * 1988-11-10 1990-05-10 Susan J. Mroczkowski Method for electrical detection of a binding reaction
US5202268A (en) * 1988-12-30 1993-04-13 Environmental Diagnostics, Inc. Multi-layered test card for the determination of substances in liquids
US5028535A (en) * 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
DE69016267T2 (en) * 1989-06-05 1995-05-24 Janssen Pharmaceutica Nv Solid phase test for use with a physical developer.
GB8915512D0 (en) 1989-07-06 1989-08-23 Sec Dep For Health Silver enhanced gold-labelled immuno assay method
US5698271A (en) * 1989-08-22 1997-12-16 Immunivest Corporation Methods for the manufacture of magnetically responsive particles
US6352863B1 (en) 1990-01-19 2002-03-05 La Mina, Inc. Assay device
US5143852A (en) * 1990-09-14 1992-09-01 Biosite Diagnostics, Inc. Antibodies to ligand analogues and their utility in ligand-receptor assays
JP2868900B2 (en) * 1991-01-11 1999-03-10 クイデル コーポレイション One-step lateral flow non-absorbable assay
US5877028A (en) 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US5607863A (en) * 1991-05-29 1997-03-04 Smithkline Diagnostics, Inc. Barrier-controlled assay device
US5998220A (en) 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
US5869345A (en) * 1991-05-29 1999-02-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing conductive barrier
US5468648A (en) * 1991-05-29 1995-11-21 Smithkline Diagnostics, Inc. Interrupted-flow assay device
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
US5840169A (en) * 1992-02-25 1998-11-24 Andersen; Peter Apparatus and process for electroelution of a gel containing charged macromolecules
US5395754A (en) * 1992-07-31 1995-03-07 Hybritech Incorporated Membrane-based immunoassay method
US5340746A (en) * 1993-01-08 1994-08-23 Minnesota Mining And Manufacturing Company Composite reactive articles for the determination of cyanide
CA2105515A1 (en) * 1993-09-03 1995-03-04 Carlos A. Santizo Lescaille Visual immunoassay method for the detection of ligands, based on the use of opaque plastic supports
US5712172A (en) 1995-05-18 1998-01-27 Wyntek Diagnostics, Inc. One step immunochromatographic device and method of use
US6319676B1 (en) 1995-05-02 2001-11-20 Carter Wallace, Inc. Diagnostic detection device and method
US5691152A (en) * 1995-11-09 1997-11-25 E. R. Squibb & Sons, Inc. Stable avidin composition
US6551794B1 (en) 1995-11-09 2003-04-22 E. R. Squibb & Sons, Inc. Stable biotinylated biomolecule composition
US5856194A (en) 1996-09-19 1999-01-05 Abbott Laboratories Method for determination of item of interest in a sample
US5795784A (en) 1996-09-19 1998-08-18 Abbott Laboratories Method of performing a process for determining an item of interest in a sample
JP4068677B2 (en) * 1996-10-25 2008-03-26 アークレイ株式会社 Gene analysis method and gene analysis kit used therefor
JP4025833B2 (en) * 1996-10-25 2007-12-26 アークレイ株式会社 Gene analysis method, gene analysis kit and gene analysis apparatus used therefor
US7153651B1 (en) 1996-10-31 2006-12-26 Inverness Medical - Biostar, Inc. Flow-through optical assay devices providing laminar flow of fluid samples, and methods of construction thereof
US5879951A (en) 1997-01-29 1999-03-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing unidirectional flow
US6103536A (en) 1997-05-02 2000-08-15 Silver Lake Research Corporation Internally referenced competitive assays
US5939252A (en) 1997-05-09 1999-08-17 Lennon; Donald J. Detachable-element assay device
WO2000021665A1 (en) * 1998-10-14 2000-04-20 Arizona Board Of Regents Immobilized silver immunoassay system
IL126776A (en) * 1998-10-27 2001-04-30 Technion Res & Dev Foundation Method for gold depositions
US6136610A (en) 1998-11-23 2000-10-24 Praxsys Biosystems, Inc. Method and apparatus for performing a lateral flow assay
US6136044A (en) * 1999-02-03 2000-10-24 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Stable coloring by in situ formation of micro-particles
WO2001066568A2 (en) * 2000-03-09 2001-09-13 Heska Corporation Use of recombinant antigens to determine the immune status of an animal
US6699722B2 (en) 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
DE10108359B4 (en) * 2001-02-21 2008-03-27 Enßlin, Walther, Dr. Detection method for reducing substances
WO2002100444A1 (en) * 2001-06-08 2002-12-19 Biosphere Medical Inc. Colloidal metal labelled microparticles, their production and use
US20030013084A1 (en) * 2001-07-12 2003-01-16 Berlock Aps Organometallic probe
US20040023415A1 (en) * 2002-03-05 2004-02-05 Konstantin Sokolov Biospecific contrast agents
US7138468B2 (en) * 2002-03-27 2006-11-21 University Of Southern Mississippi Preparation of transition metal nanoparticles and surfaces modified with (CO)polymers synthesized by RAFT
US7883899B2 (en) * 2002-10-11 2011-02-08 Zbx Corporation Diagnostic devices
CA2834041C (en) * 2003-12-31 2017-05-16 President And Fellows Of Harvard College Assay device and method
US7638093B2 (en) * 2004-01-28 2009-12-29 Dnt Scientific Research, Llc Interrupted flow rapid confirmatory immunological testing device and method
US7465587B2 (en) 2004-12-03 2008-12-16 Genzyme Corporation Diagnostic assay device
US20060292700A1 (en) * 2005-06-22 2006-12-28 Naishu Wang Diffused interrupted lateral flow immunoassay device and method
CN101184999B (en) * 2005-05-23 2013-03-27 法迪亚股份有限公司 Two step lateral flow assay methods and devices
US20070015166A1 (en) * 2005-07-14 2007-01-18 Nilsen Thor W Lateral flow methods and devices for detection of nucleic acid binding proteins
EP1962093B1 (en) * 2005-11-25 2013-06-12 Japan Science and Technology Agency Analysis method
US7879623B2 (en) * 2006-03-31 2011-02-01 Guirguis Raouf A Integrated device for analyte, testing, confirmation, and donor identity verification
US11906512B2 (en) 2006-03-31 2024-02-20 Zeus Diagnostics, LLC Integrated device for analyte testing, confirmation, and donor identity verification
US8940527B2 (en) * 2006-03-31 2015-01-27 Lamina Equities Corp. Integrated device for analyte testing, confirmation, and donor identity verification
US7741103B2 (en) * 2006-03-31 2010-06-22 Guirguis Raouf A Integrated screening and confirmation device
US7569396B1 (en) 2006-09-08 2009-08-04 Purplecow Llc Caffeine detection using internally referenced competitive assays
US7919331B2 (en) * 2006-12-21 2011-04-05 Silver Lake Research Corporation Chromatographic test strips for one or more analytes
JP4980946B2 (en) * 2008-02-12 2012-07-18 富士フイルム株式会社 Blotting detection method
JP4870695B2 (en) * 2008-02-12 2012-02-08 富士フイルム株式会社 How to wash, amplify and stop labels in the membrane
US8673644B2 (en) 2008-05-13 2014-03-18 Battelle Memorial Institute Serum markers for type II diabetes mellitus
US8476008B2 (en) * 2008-07-23 2013-07-02 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes
US20100047913A1 (en) * 2008-08-19 2010-02-25 The Trustees Of The University Of Pennsylvania Colloidal Gold Single Reagent Quantitative Protein Assay
CA2750818A1 (en) 2009-01-27 2010-08-05 Proteogenix, Inc. Biomarkers for detection of neonatal sepsis in biological fluid
EP2391892B1 (en) 2009-01-30 2017-01-18 Mycartis N.V. Biomarker for diagnosis of acute heart failure and uses thereof
US8168396B2 (en) 2009-05-11 2012-05-01 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
DK2491401T3 (en) 2009-10-21 2018-06-25 Mycartis N V MCAM as a biomarker for fluid homeostasis
ES2677944T3 (en) 2009-11-25 2018-08-07 Hologic Inc. Detection of intraamniotic infection
EP2553461B1 (en) 2010-03-26 2016-01-20 Mycartis N.V. Ltbp2 as a biomarker for renal dysfunction and glomerular filtration rate
US20130045889A1 (en) 2010-04-13 2013-02-21 Pronota N.V. Biomarkers for hypertensive disorders of pregnancy
CN102906567B (en) * 2010-04-14 2015-02-04 日东纺绩株式会社 Test instrument for measuring analyte in sample, and method for measuring analyte using same
WO2011150186A1 (en) 2010-05-26 2011-12-01 The Board Of Trustees Of The University Of Illinois Personal glucose meters for detection and quantification of a broad range of analytes
CA2802305A1 (en) 2010-07-08 2012-01-12 Pronota N.V. Biomarker for hypertensive disorders of pregnancy
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
CA2819886A1 (en) 2010-12-06 2012-06-14 Pronota N.V. Biomarkers and parameters for hypertensive disorders of pregnancy
US20150045245A1 (en) 2011-12-08 2015-02-12 Biocartis Nv Biomarkers and test panels useful in systemic inflammatory conditions
RU2673074C2 (en) 2011-12-15 2018-11-22 Майкартис Н.В. Biomarkers and parameters for hypertensive disorders during pregnancy
US10139405B2 (en) 2012-01-24 2018-11-27 Cd Diagnostics, Inc. System for detecting infection in synovial fluid
US20140248629A1 (en) * 2013-03-03 2014-09-04 Morteza Mahmoudi Gold nanoparticle based dipstick nano-biosensor for detecting plasmodium falciparum and plasmodium vivax and mehtod of synthesizing the same
US9383352B2 (en) 2014-03-26 2016-07-05 Diabetomics, Inc. Salivary protein glycosylation test for diagnosis and monitoring of diabetes
GB2552427A (en) 2015-01-29 2018-01-24 Neogen Corp Methods for immuno chromatographic assay desensitization
US10584162B2 (en) 2015-04-23 2020-03-10 Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, Reno Fungal detection using mannan epitope
CA2994416A1 (en) 2015-08-04 2017-02-09 Cd Diagnostics, Inc. Methods for detecting adverse local tissue reaction (altr) necrosis
US10151749B2 (en) * 2015-08-05 2018-12-11 Alfaisal University Method and kit for the detection of microorganisms
US20200200735A9 (en) 2016-02-22 2020-06-25 Ursure, Inc. System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
EP3442993B1 (en) 2016-04-13 2021-01-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and kits for the rapid detection of the escherichia coli o25b-st131 clone
US10564155B2 (en) 2017-01-27 2020-02-18 Raouf A Guirguis Dual swab fluid sample collection for split sample testing and fingerprint identification device
US12282029B2 (en) 2017-05-08 2025-04-22 MPB Fertility, Inc. Portable diagnostic system for ovulation cycle monitoring
US11061026B2 (en) 2017-02-17 2021-07-13 MFB Fertility, Inc. System of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
WO2018211126A1 (en) 2017-05-19 2018-11-22 Philip Morris Products S.A. Diagnostic test for distinguishing the smoking status of a subject
WO2019152657A1 (en) 2018-02-03 2019-08-08 Simple Healthkit, Inc. Reliable, comprehensive, and rapid sexual health assessment
US12181465B2 (en) 2018-08-22 2024-12-31 MFB Fertility, Inc. Method for evaluating urine of a subject to estimate the fertile window by evaluating for the presence of analytes of estrogen and progesterone
US11300576B2 (en) 2019-01-29 2022-04-12 Arizona Board Of Regents On Behalf Of Arizona State University DARPin reagents that distinguish Alzheimer's disease and Parkinson's disease samples

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115198A (en) * 1974-02-11 1978-09-19 Coughlin Robert W Method of immobilization of biologically active organic substances including enzymes
IL49685A (en) * 1976-05-31 1978-10-31 Technion Res & Dev Foundation Specific binding assay method for determining the concentration of materials and reagent means therefor
US4208185A (en) * 1976-08-16 1980-06-17 Mitsubishi Chemical Industries Limited Method and apparatus for the measurement of antigens and antibodies
US4203724A (en) * 1976-08-16 1980-05-20 Mitsubishi Chemical Industries Limited Method and apparatus for the measurement of antigens and antibodies
SE431257B (en) * 1977-11-03 1984-01-23 Du Pont SET AND DEVICE FOR IMMUNAL ANALYSIS WITH MAGNETIC METAL OR METAL OXIDE AS A BRAND
NL7807532A (en) * 1978-07-13 1980-01-15 Akzo Nv METAL IMMUNO TEST.
US4420558A (en) * 1981-02-12 1983-12-13 Janssen Pharmaceutica N.V. Bright field light microscopic method of enumerating and characterizing subtypes of white blood cells and their precursors
US4487839A (en) * 1983-01-05 1984-12-11 Ortho Diagnostic Systems Inc. Immunoassay methods employing patterns for the detection of soluble and cell surface antigens
CA1260827A (en) * 1984-08-31 1989-09-26 Richard C. Siegel Antibody-metal ion complexes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079172A (en) 1988-11-04 1992-01-07 Board Of Trustees Operating Michigan State University Method for detecting the presence of antibodies using gold-labeled antibodies and test kit

Also Published As

Publication number Publication date
FI80345B (en) 1990-01-31
ES537926A0 (en) 1985-11-01
PT79533A (en) 1984-12-01
KR850003728A (en) 1985-06-26
FI844508L (en) 1985-05-26
DK160108B (en) 1991-01-28
ES8602255A1 (en) 1985-11-01
JPS60185160A (en) 1985-09-20
ZA849182B (en) 1986-06-25
FI844508A0 (en) 1984-11-16
DK160108C (en) 1995-07-24
EP0158746A3 (en) 1987-09-23
DK557684D0 (en) 1984-11-23
NZ210309A (en) 1987-04-30
AU583484B2 (en) 1989-05-04
JPH0643162A (en) 1994-02-18
FI80345C (en) 1992-11-16
NO163754C (en) 1993-01-12
IL73607A0 (en) 1985-02-28
DK557684A (en) 1985-05-26
IL73607A (en) 1988-12-30
DE3484710D1 (en) 1991-07-18
EP0158746B1 (en) 1991-06-12
AU3582584A (en) 1985-05-30
CA1253422A (en) 1989-05-02
HK14894A (en) 1994-03-04
ATE64468T1 (en) 1991-06-15
KR890001131B1 (en) 1989-04-24
NO163754B (en) 1990-04-02
JP2601616B2 (en) 1997-04-16
US4775636A (en) 1988-10-04
CY1759A (en) 1994-07-15
EP0158746A2 (en) 1985-10-23
JPH0643998B2 (en) 1994-06-08
NO844672L (en) 1985-05-28

Similar Documents

Publication Publication Date Title
GB8331514D0 (en) Visualization method
AU554830B2 (en) Composition for detecting leukocytes containing a zwitterion coupling agent
SG70992G (en) Chromatographic device and method
EP0135324A3 (en) Method and means for determination of analytes in a particle-containing medium
EP0103558A3 (en) Method for quantitative determination of a biospecific affinity reaction
ES8607233A1 (en) Novel compounds for detecting the presence of hydrolytic analytes in a test sample.
DE3361905D1 (en) Test for esterase activity in a liquid sample
AU3765989A (en) Reducible indicators containing pyrogallol and use thereof
DE3265522D1 (en) Method for preparing a chromogen reactive for determining the serum iron concentration and binding power, and the chromogen reactive obtained thereby
RO80976A2 (en) INSTALLATION FOR DETERMINING THE RHEOLOGICAL BEHAVIOR OF HARD ROCKS
Golden et al. A radioisotopic study of the effect of surface conditions during wear of Tungsten carbid
JPS5754733A (en) Method of compensating characteristic of electromagnetic clutch or the like